Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology.

Abstract

The liver is extremely active in oxidizing triglycerides (TG) for energy production. An imbalance between TG synthesis and hydrolysis leads to metabolic disorders in the liver, including excessive lipid accumulation, oxidative stress, and ultimately liver damage. Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme that catalyzes the first step of TG breakdown to glycerol and fatty acids. Although its role in controlling lipid homeostasis has been relatively well-studied in the adipose tissue, heart, and skeletal muscle, it remains largely unknown how and to what extent ATGL is regulated in the liver, responds to stimuli and regulators, and mediates disease progression. Therefore, in this review, we describe the current understanding of the structure-function relationship of ATGL, the molecular mechanisms of ATGL regulation at translational and post-translational levels, and-most importantly-its role in lipid and glucose homeostasis in health and disease with a focus on the liver. Advances in understanding the molecular mechanisms underlying hepatic lipid accumulation are crucial to the development of targeted therapies for treating hepatic metabolic disorders.

• Authors: Tianjiao Li, Wei Guo, Zhanxiang Zhou
• Journal: Biomolecules (Biomolecules) Vol. 12 Issue 1 (12 31 2021) ISSN: 2218-273X [Electronic] Switzerland
• PMID: 35053204 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)

Chemical References

• Triglycerides
• Lipase

Topics

• Adipose Tissue (metabolism)
• Lipase (metabolism)
• Lipolysis
• Liver (metabolism)
• Triglycerides (metabolism)